tiprankstipranks
Advertisement
Advertisement

ADCT Stock Latest News

Buy Rating Reiterated on Strong Execution and Pipeline Catalysts; 12-Month Price Target Maintained at $8
RatingsBuy Rating Reiterated on Strong Execution and Pipeline Catalysts; 12-Month Price Target Maintained at $8
11h ago
ADCT
ADC Therapeutics Balances Solid Quarter With Trial Risk
PremiumCompany Announcements
ADC Therapeutics Balances Solid Quarter With Trial Risk
21h ago
ADCT
ADC Therapeutics reports Q1 EPS (13c) vs. (22c) last year
PremiumThe Fly
ADC Therapeutics reports Q1 EPS (13c) vs. (22c) last year
1d ago
ADCT
ADC Therapeutics Ltd (ADCT) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
ADC Therapeutics Ltd (ADCT) Q1 Earnings Cheat Sheet
4d ago
ADCT
ADC Therapeutics Earnings Call: Trials, Cash And Risks
PremiumCompany Announcements
ADC Therapeutics Earnings Call: Trials, Cash And Risks
1M ago
ADCT
ADC Therapeutics: Strengthening Fundamentals, ZYNLONTA Pipeline Momentum, and Increased $8 Target Support Buy Rating
PremiumRatingsADC Therapeutics: Strengthening Fundamentals, ZYNLONTA Pipeline Momentum, and Increased $8 Target Support Buy Rating
1M ago
ADCT
ADC Therapeutics price target raised to $8 from $7 at H.C. Wainwright
Premium
The Fly
ADC Therapeutics price target raised to $8 from $7 at H.C. Wainwright
1M ago
ADCT
ADC Therapeutics files to sell 9.83M common shares for holders
Premium
The Fly
ADC Therapeutics files to sell 9.83M common shares for holders
2M ago
ADCT
ADC Therapeutics reports Q4 adjusted EPS (9c), consensus (27c)
PremiumThe Fly
ADC Therapeutics reports Q4 adjusted EPS (9c), consensus (27c)
2M ago
ADCT
ADC Therapeutics sees cash runway at least into 2028
PremiumThe Fly
ADC Therapeutics sees cash runway at least into 2028
2M ago
ADCT
ADC Therapeutics Ltd (ADCT) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
ADC Therapeutics Ltd (ADCT) Q4 Earnings Cheat Sheet
2M ago
ADCT
ADC Therapeutics Amends Royalty Deal, Issues New Warrants
PremiumCompany Announcements
ADC Therapeutics Amends Royalty Deal, Issues New Warrants
2M ago
8K
ADCT
ADC Therapeutics announces amended HealthCare Royalty financing agreement
PremiumThe FlyADC Therapeutics announces amended HealthCare Royalty financing agreement
2M ago
ADCT
ADC Therapeutics participates in a conference call with Cantor
Premium
The Fly
ADC Therapeutics participates in a conference call with Cantor
3M ago
ADCT
ADC Therapeutics outlines ZYNLONTA-focused growth and financing strategy
Premium
Company Announcements
ADC Therapeutics outlines ZYNLONTA-focused growth and financing strategy
4M ago
8K
ADCT
ADC Therapeutics Announces Preliminary 2025 Financial Results and Outlook
PremiumCompany Announcements
ADC Therapeutics Announces Preliminary 2025 Financial Results and Outlook
4M ago
8K
ADCT
ADC Therapeutics sees FY25 net product revenue $73M
PremiumThe Fly
ADC Therapeutics sees FY25 net product revenue $73M
4M ago
ADCT
ADC Therapeutics sees Q4 net product revenue $22M
PremiumThe Fly
ADC Therapeutics sees Q4 net product revenue $22M
4M ago
ADCT
ADC Therapeutics Reports Promising LOTIS-7 Trial Results
PremiumCompany Announcements
ADC Therapeutics Reports Promising LOTIS-7 Trial Results
5M ago
8K
ADCT
Promising LOTIS-7 Trial Results Reinforce Buy Rating for ADC Therapeutics
PremiumRatingsPromising LOTIS-7 Trial Results Reinforce Buy Rating for ADC Therapeutics
5M ago
ADCT
ADC Therapeutics updates data from Phase 1b trial of Zynlonta in lymphoma
Premium
The Fly
ADC Therapeutics updates data from Phase 1b trial of Zynlonta in lymphoma
5M ago
ADCT
ADC Therapeutics: Strong Financials and Upcoming Trial Catalysts Support Buy Rating
Premium
Ratings
ADC Therapeutics: Strong Financials and Upcoming Trial Catalysts Support Buy Rating
6M ago
ADCT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >